These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 26044919)

  • 41. Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial.
    Backeljauw PF; Miller BS; Dutailly P; Houchard A; Lawson E; Hale DE; Reiner B; Sperling MA;
    Horm Res Paediatr; 2015; 83(4):268-79. PubMed ID: 25765099
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency.
    Zucchini S; Pirazzoli P; Baronio F; Gennari M; Bal MO; Balsamo A; Gualandi S; Cicognani A
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4271-6. PubMed ID: 16912138
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Growth, growth hormone and final height after BMT. Possible recovery of irradiation-induced growth hormone insufficiency.
    Holm K; Nysom K; Rasmussen MH; Hertz H; Jacobsen N; Skakkebaek NE; Krabbe S; Müller J
    Bone Marrow Transplant; 1996 Jul; 18(1):163-70. PubMed ID: 8832010
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
    Lanes R; Gunczler P; Lopez E; Esaa S; Villaroel O; Revel-Chion R
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The -202 A allele of insulin-like growth factor binding protein-3 (IGFBP3) promoter polymorphism is associated with higher IGFBP-3 serum levels and better growth response to growth hormone treatment in patients with severe growth hormone deficiency.
    Costalonga EF; Antonini SR; Guerra-Junior G; Mendonca BB; Arnhold IJ; Jorge AA
    J Clin Endocrinol Metab; 2009 Feb; 94(2):588-95. PubMed ID: 18984657
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Somatomedin-C and growth in children with precocious puberty: a study of the effect of the level of growth hormone secretion.
    Rappaport R; Prevot C; Brauner R
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1112-7. PubMed ID: 3680478
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects.
    Hilding A; Brismar K; Degerblad M; Thorén M; Hall K
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2646-52. PubMed ID: 7545695
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combined test of hypothalamic-pituitary function in growth retarded children treated with growth hormone. I. Secretion of growth hormone and somatomedin before and after treatment.
    Kastrup KW; Andersen H; Eskildsen PC; Jacobsen BB; Krabbe S; Petersen KE
    Acta Paediatr Scand Suppl; 1979; 277():8-13. PubMed ID: 396757
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Short-term pharmacologically induced growth study of ontogenetic allometry of oxygen uptake in children.
    Balasekaran G; Robertson RJ; Goss FL; Suprasongsin C; Danadian K; Govindaswamy V; Arslanian SA
    Ann Hum Biol; 2005; 32(6):746-59. PubMed ID: 16418048
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Response to growth hormone treatment in isolated growth hormone deficiency versus multiple pituitary hormone deficiency.
    Darendeliler F; Lindberg A; Wilton P
    Horm Res Paediatr; 2011; 76 Suppl 1():42-6. PubMed ID: 21778748
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Significant increase of IGF-I concentration and of IGF-I/IGFBP-3 molar ratio in generation test predicts the good response to growth hormone (GH) therapy in children with short stature and normal results of GH stimulating tests.
    Smyczynska J; Hilczer M; Stawerska R; Lewinski A
    Neuro Endocrinol Lett; 2013; 34(3):222-8. PubMed ID: 23685421
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impaired GH secretion in patients with SHOX deficiency and efficacy of recombinant human GH therapy.
    Iughetti L; Vannelli S; Street ME; Pirazzoli P; Bertelloni S; Radetti G; Capone L; Stasiowska B; Mazzanti L; Gastaldi R; Maggio MC; Predieri B
    Horm Res Paediatr; 2012; 78(5-6):279-87. PubMed ID: 23208451
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Growth hormone (GH) provocative testing frequently does not reflect endogenous GH secretion.
    Bercu BB; Shulman D; Root AW; Spiliotis BE
    J Clin Endocrinol Metab; 1986 Sep; 63(3):709-16. PubMed ID: 3525601
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Growth hormone therapy.
    Dash RJ; Muralidharan R; Talwar V
    J Assoc Physicians India; 1999 Apr; 47(4):417-25. PubMed ID: 10778529
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 6-Hydroxymelatonin sulfate excretion in human puberty.
    Cavallo A; Dolan LM
    J Pineal Res; 1996 Nov; 21(4):225-30. PubMed ID: 8989721
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of gender on the correlation between plasma growth hormone profiles and urinary growth hormone excretion.
    Main KM; Jansson C; Skakkebak N; Albertsson-Wikland K
    Horm Res; 1997; 48(1):16-22. PubMed ID: 9195205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Melatonin response in active epilepsy.
    Schapel GJ; Beran RG; Kennaway DL; McLoughney J; Matthews CD
    Epilepsia; 1995 Jan; 36(1):75-8. PubMed ID: 8001514
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Melatonin excretion in normal children and in tuberous sclerosis complex with sleep disorder responsive to melatonin.
    Hancock E; O'Callaghan F; English J; Osborne JP
    J Child Neurol; 2005 Jan; 20(1):21-5. PubMed ID: 15791917
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urinary 6-sulfatoxymelatonin excretion and aging: new results and a critical review of the literature.
    Kennaway DJ; Lushington K; Dawson D; Lack L; van den Heuvel C; Rogers N
    J Pineal Res; 1999 Nov; 27(4):210-20. PubMed ID: 10551768
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Total Daily Production and Periodicity of Melatonin Metabolite in Critically Ill Children.
    Foster JR; Tijssen JA; Miller MR; Seabrook JA; Fraser DD
    Pediatr Crit Care Med; 2020 Dec; 21(12):e1061-e1068. PubMed ID: 32701747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.